| 11584724 |
Process for synthesis of a phenoxy diaminopyrimidine compound |
Kevin M. Maloney, Kallol Basu, Michael James Di Maso, Guy R. Humphrey, Feng Peng +2 more |
2023-02-21 |
| 11292810 |
Inclusion complexes of an HCV NS5B inhibitor and uses thereof |
Michael McNevin, Jason T. Ash, Itzia Arroyo, Binfeng Xia |
2022-04-05 |
| 10301281 |
Crystal forms of a CCR5 antagonist |
William De Wildt |
2019-05-28 |
| 10167298 |
Pseudopolymorphs of an HCV NS5A inhibitor and uses thereof |
Michael McNevin, Yong Liu, Ian Mangion, Joyce Stellabott, Benjamin D. Sherry +5 more |
2019-01-01 |
| 10058544 |
(S)-N-(3-(6-isopropoxypyridin-3-yl)-1H-indazol-5-yl)-1-(2-(4-(4-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2H)-yl)-2-oxoethyl)-3-(methylthio)pyrrolidine-3-carboxamide compositions for pharmaceutical preparations |
Deepak Bahl, Yung-Chi Lee, William Anthony Marinaro, Jr., Dan Zhang, Tao Feng |
2018-08-28 |
| 7329319 |
Method for producing crystals and screening crystallization conditions |
Allan S. Myerson |
2008-02-12 |
| 7329592 |
Method for screening crystallization conditions using multifunctional substrates |
Allan S. Myerson |
2008-02-12 |
